SAM
HCAT icon

Smartleaf Asset Management’s Health Catalyst HCAT Stock Holding History

Smartleaf Asset Management’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.26K Buy
1,918
+570
+42% +$1.07K ﹤0.01% 2925
2025
Q4 		$3.21K Buy
1,348
+622
+86% +$1.7K ﹤0.01% 2840
2025
Q3 		$2.12K Buy
726
+549
+310% +$1.88K ﹤0.01% 2604
2025
Q2 		$674 Sell
177
-247
-58% -$972 ﹤0.01% 2545
2025
Q1 		$1.93K Sell
424
-47
-10% -$249 ﹤0.01% 2480
2024
Q4 		$3.3K Sell
471
-460
-49% -$3.66K ﹤0.01% 2384
2024
Q3 		$7.74K Buy
931
+884
+1,881% +$6.39K ﹤0.01% 1910
2024
Q2 		$284 Buy
+47
New +$302 ﹤0.01% 2639

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Smartleaf Asset Management's HCAT Position: Q1 2026 in Review

Smartleaf Asset Management increased its Health Catalyst (HCAT) stake by 42% in Q1 2026, buying an estimated $1.07K and bringing the position to 1,918 shares worth $2.26K. The position accounts for ﹤0.01% of the portfolio, ranked #2925.

Smartleaf Asset Management first reported a position in HCAT in Q2 2024 and has held it in 8 quarters since. The position peaked at $7.74K in Q3 2024. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Smartleaf Asset Management held 1,918 shares of Health Catalyst worth $2.26K as of Q1 2026.
  • Smartleaf Asset Management bought 570 Health Catalyst shares in Q1 2026, an estimated $1.07K.
  • Health Catalyst made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #2925 holding.
  • Smartleaf Asset Management first reported a position in Health Catalyst in Q2 2024 and has held it in 8 quarters since.
  • Smartleaf Asset Management's Health Catalyst position peaked at $7.74K in Q3 2024.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.